Initial antibiotic therapy for staphylococcal scalded skin syndrome in children

Children with staphylococcal scalded skin syndrome require admission to hospital and intravenous antibiotics.

Empirical therapy should treat methicillin-susceptible Staphylococcus aureus (MSSA). Treatment for methicillin-resistant S. aureus (MRSA) is added for children who are severely unwell or have risk factors for infection with MRSA.

For children with staphylococcal scalded skin syndrome, use:

1cefazolin 50 mg/kg up to 2 g intravenously, 8-hourly. For children with septic shock or requiring intensive care support, use a 6-hourly dosing interval. See advice on modification and duration of therapy cefazolin

OR

1flucloxacillin 50 mg/kg up to 2 g intravenously, 6-hourly. For children with septic shock or requiring intensive care support, use a 4-hourly dosing interval. See advice on modification and duration of therapy flucloxacillin

PLUS if the child is severely unwell or has risk factors for MRSA infection

vancomycin intravenously; for initial dosing, see Principles of vancomycin use for children. See also advice on modification and duration of therapy. vancomycin

In some regions, based on local susceptibility data, clindamycin is a suitable alternative to vancomycin. If clindamycin is preferred, replace vancomycin in the above regimen with:

clindamycin 15 mg/kg up to 600 mg intravenously, 8-hourly1. See advice on modification and duration of therapy. clindamycin

There have been reports of clindamycin being added to antibiotic therapy because of a theoretical reduction in staphylococcal toxin production. However, evidence is lacking and this is not routinely recommendedBrazel, 2021Liy-Wong, 2021.The addition of clindamycin may be considered in severely unwell children; seek expert advice.

For children who have had a nonsevere (immediate or delayed) hypersensitivity reaction to a penicillin, use the cefazolin regimen above.

For children who have had a severe immediate2 hypersensitivity reaction to a penicillin, the cefazolin regimen above can be considered if a beta-lactam antibiotic is strongly preferred (for considerations, see Severe immediate hypersensitivity: Implications of cross-reactivity between penicillins and cephalosporins).

For children who have had a severe immediate2 hypersensitivity reaction to a penicillin in whom cefazolin is not used, or for children who have had a severe delayed3 hypersensitivity reaction to a penicillin, use vancomycin alone (see dosage above).

1 There are more clinical and microbiological data to support the use of clindamycin than lincomycin. Intravenous lincomycin can be used at the same dosage if clindamycin is unavailable or if a local protocol recommends its use.Return
2 Severe immediate hypersensitivity reactions include anaphylaxis, compromised airway, airway angioedema, hypotension and collapse.Return
3 Severe delayed hypersensitivity reactions include cutaneous adverse drug reactions (eg drug rash with eosinophilia and systemic symptoms [DRESS], Stevens–Johnson syndrome/toxic epidermal necrolysis [SJS/TEN], severe blistering or desquamative rash), and significant internal organ involvement (eg acute interstitial nephritis).Return